E-LIB Suche - Ergebnisse für: Grunnet, Kirsten

1

BIOM-24. PREDICTION OF DISTANT RECURRENCE IN GLIOBLASTOMA P..:

Chiranth, Shivani ; Trip, Anouk ; Christensen, Ib...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v9-v9 , 2023

Link: https://doi.org/10.1093/..

2

A Prognostic Model for Glioblastoma Patients Treated With S..:

Abedi, Armita Armina ; Grunnet, Kirsten ; Christensen, Ib Jarle...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

3

RARE-21. CLINICAL CHARACTERISTICS OF GLIOSARCOMA AND OUTCOM..:

Frandsen, Simone ; Broholm, Helle ; Larsen, Vibeke A...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi225-vi226 , 2019

Link: https://doi.org/10.1093/..

4

Clinical Characteristics of Gliosarcoma and Outcomes From S..:

Frandsen, Simone ; Broholm, Helle ; Larsen, Vibeke Andrée...
Frontiers in Oncology. 9 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

5

EPID-13. IDENTIFICATION OF PROGNOSTIC MARKERS IN A COHORT O..:

Regner Michaelsen, Signe ; Urup, Thomas ; Grunnet, Kirsten...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi77-vi77 , 2019

Link: https://doi.org/10.1093/..

6

ABCB1 single-nucleotide variants and survival in patients w..:

Malmström, Annika ; Łysiak, Malgorzata ; Åkesson, Lisa...
The Pharmacogenomics Journal. 20 (2019) 2 - p. 213-219 , 2019

Link: https://doi.org/10.1038/..

7

Recurrent glioblastoma versus late posttreatment changes: d..:

Bashir, Asma ; Mathilde Jacobsen, Sofie ; Mølby Henriksen, Otto...
Neuro-Oncology. 21 (2019) 12 - p. 1595-1606 , 2019

Link: https://doi.org/10.1093/..

8

ACTR-26. TOXICITY AND EFFICACY OF LOMUSTINE PLUS BEVACIZUMA..:

Jakobsen, Jan Nyrop ; Urup, Thomas ; Grunnet, Kirsten...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi6-vi6 , 2017

Link: https://doi.org/10.1093/..

9

PATH-01. IDENTIFICATION OF PROGNOSTIC VARIABLES BASED ON MO..:

Michaelsen, Signe Regner ; Urup, Thomas ; Olsen, Lars Rønn...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi170-vi170 , 2017

Link: https://doi.org/10.1093/..

10

Assessment of Quantitative and AllelicMGMTMethylation Patte..:

Kristensen, Lasse S. ; Michaelsen, Signe R. ; Dyrbye, Henrik...
Journal of Neuropathology & Experimental Neurology. 75 (2016) 3 - p. 246-255 , 2016

Link: https://doi.org/10.1093/..

11

The prognostic value of FET PET at radiotherapy planning in..:

Poulsen, Sidsel Højklint ; Urup, Thomas ; Grunnet, Kirsten...
European Journal of Nuclear Medicine and Molecular Imaging. 44 (2016) 3 - p. 373-381 , 2016

Link: https://doi.org/10.1007/..

12

RTHP-20. EVALUATION OF RADIATION THERAPY TECHNOLOGY AND DOS..:

Rosenschold, Per Munck af ; Law, Ian ; Engelholm, Svend Aage...
Neuro-Oncology. 18 (2016) suppl_6 - p. vi178-vi178 , 2016

Link: https://doi.org/10.1093/..

13

Angiotensinogen and HLA class II predict bevacizumab respon..:

Urup, Thomas ; Michaelsen, Signe Regner ; Olsen, Lars Rønn...
Molecular Oncology. 10 (2016) 8 - p. 1160-1168 , 2016

Link: https://doi.org/10.1016/..

14

MTR-18PREDICTIVE BIOMARKERS OF BEVACIZUMAB RESPONSE IN RECU..:

Urup, Thomas ; Michaelsen, Signe Regner ; Olsen, Lars Rønn...
Neuro-Oncology. 17 (2015) suppl 5 - p. v128.2-v128 , 2015

Link: https://doi.org/10.1093/..

15

NIMG-34THE PROGNOSTIC VALUE OF POSTOPERATIVE O-(2-18F-FLUOR..:

Poulsen, Sidsel Højklint ; Urup, Thomas ; Grunnet, Kirsten...
Neuro-Oncology. 17 (2015) suppl 5 - p. v161.2-v161 , 2015

Link: https://doi.org/10.1093/..